Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC422

Faricímab

  • Status:
    Veitt
  • Application date:
    13.2.2023
  • Application published:
    15.3.2023
  • Grant published:
    15.12.2023
  • Max expiry date:
    15.9.2037
  • Medicine name:
    Vabysmo
  • Medicine for children:
    No

Timeline

Today
13.2.2023Application
15.3.2023Publication
15.12.2023Registration
15.9.2037Expires

Marketing license

  • IS authorization number:
    EU/1/22/1683/001
  • Date:
    11.10.2022
  • Foreign authorization number:
    EU/1/22/1683
  • Date:
    15.9.2022

Owner

  • Name:
    F. Hoffmann-La Roche AG
  • Address:
    Grenzacherstrasse 124, CH-4070 Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 30.11.2023

Upload documents